174 related articles for article (PubMed ID: 22234140)
1. Systemic mastocytosis with an associated non mast cell lineage clonal hematological disease in a child.
Sharma S; Harbhajanka A; Jain A; Seth A
Indian J Pathol Microbiol; 2011; 54(4):854-6. PubMed ID: 22234140
[No Abstract] [Full Text] [Related]
2. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
3. Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).
Gadage VS; Kadam Amare PS; Galani KS; Mittal N
Indian J Pathol Microbiol; 2012; 55(3):409-12. PubMed ID: 23032848
[TBL] [Abstract][Full Text] [Related]
4. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
5. Seventy-four-year-old woman with myelodysplastic syndrome and splenomegaly.
Motosue A; Alperin J; Elghetany MT; Bonds R
Allergy Asthma Proc; 2010; 31(3):252-7. PubMed ID: 20615327
[TBL] [Abstract][Full Text] [Related]
6. Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.
Pourhassan H; Kim Y; Pullarkat V
Eur J Haematol; 2023 Feb; 110(2):213-216. PubMed ID: 36335580
[TBL] [Abstract][Full Text] [Related]
7. Mast cell disease: surgical and anesthetic implications.
Damodar S; John CN; Gopalakrishnan G; Nair S; Samuel R; Thomas M; Shetty DP
J Pediatr Hematol Oncol; 2006 Jul; 28(7):446-9. PubMed ID: 16825991
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.
Escribano L; Garca-Montero A; Núñez-López R; López-Jiménez J; Almeida J; Prados A; Orfao A
J Allergy Clin Immunol; 2004 Jul; 114(1):28-33. PubMed ID: 15241340
[TBL] [Abstract][Full Text] [Related]
10. [Systemic mastocytosis].
Fain O; Stirnemann J; Lortholary O
Rev Prat; 2005 Oct; 55(15):1629-36. PubMed ID: 16334197
[TBL] [Abstract][Full Text] [Related]
11. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukemia (AML-M2) with mast cell hyperplasia of bone marrow: a report of three cases.
Adhya AK; Varma N; Varma S
Indian J Pathol Microbiol; 2007 Jul; 50(3):655-8. PubMed ID: 17883174
[TBL] [Abstract][Full Text] [Related]
13. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
[TBL] [Abstract][Full Text] [Related]
14. Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases.
Mimiola E; Bomben R; De Matteis G; Perbellini O; Guglielmelli P; Bonifacio M; Parisi A; Gattei V; Zamò A; Mannelli F; García Montero AC; Zanotti R
Hematol Oncol; 2019 Dec; 37(5):628-633. PubMed ID: 31523839
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity.
El Hussein S; Hu S; Fang H; Garces S; Muzzafar T; Wang SA; Medeiros LJ; Bueso-Ramos C; Jelloul FZ
Leuk Lymphoma; 2022 Jan; 63(1):235-238. PubMed ID: 34510998
[No Abstract] [Full Text] [Related]
16. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
17. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
Kim Y; Weiss LM; Chen YY; Pullarkat V
Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
19. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
Stamm AC; Burbelko M; Rominger M
Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
[No Abstract] [Full Text] [Related]
20. Efficacy of lenalidomide in a patient with systemic mastocytosis associated with
Sarmiento M; Rocca GS; Rahhal M; Lincango Yupanki M; Zubieta M; Metrebian F; Narbaitz M; Larripa IB; Belli CB
Leuk Lymphoma; 2021 Dec; 62(12):3027-3030. PubMed ID: 34151705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
